Adam L. Boxer MD PhD
Endowed Professor in Memory and Aging, University of California, San Francisco
Join to view full profile
400 Parnassus AveSan Francisco, CA 94143
Phone+1 415-353-2273
Fax+1 415-476-4150
Dr. Boxer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1999 - 2002
Sutter Health/California Pacific Medical CenterInternship, Internal Medicine, 1998 - 1999
New York University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Longitudinal cognitive outcomes in two progressive supranuclear palsy clinical trials.Zoë C Cooper, Indira Garcia-Cordero, Maria Carmela Tartaglia, Adam M Staffaroni, Kevin Duff
Alzheimer's & Dementia. 2026-07-01 - Development and validation of a harmonized memory score for multicenter Alzheimer's disease and related dementia research.Mark Sanderson-Cimino, Alden L Gross, Leslie S Gaynor, Emily W Paolillo, Rowan Saloner
Alzheimer's Research & Therapy. 2026-06-15 - The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Coho...Monica Rivera-Mindt, Micah J Savin, Vanessa Guzman, Alyssa Arentoft, Eden V Barragan
Medrxiv. 2026-06-02
Press Mentions
Alzheimer’s Blood Tests Offer New Promise to Diagnose and Predict the DiseaseJuly 15th, 2026- Advancing Hope: AFTD Helps Organize C9orf72 Prevention Trial WorkshopOctober 3rd, 2025
- How Do Middle-Aged Folks Get Dementia? It Could Be These ProteinsMay 14th, 2025
Grant Support
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)MAYO CLINIC ROCHESTER2019–2030
- The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- The Alzheimer's Disease Tau Platform Clinical TrialUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
- Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDPUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2027
- Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
